Risk for GI Symptoms Increases with Obesity

Published Online: Monday, November 1, 2004

Obesity has reached epidemic proportions. The relationship between obesity and gastrointestinal (GI) tract symptomatology, however, remains poorly understood.

In the September 2004 issue of The American Journal of Gastroenterology, Silvia Delgado-Aros, MD, PhD, and colleagues reported the results of their study on the relationship between body mass index (BMI) and specific GI symptoms in individuals in the community. Results from 1963 residents of Olmsted County, Minn, demonstrated that the prevalence of obesity (BMI ≥ 30 kg/m2) in this group was 23%. Positive correlations were noted between BMI and frequent vomiting (P = .02), upper abdominal pain (P = .03), bloating (P = .002), and diarrhea (P = .01). Although the prevalence of lower abdominal pain, nausea, and constipation increased with increasing BMI, no significant associations between BMI and these symptoms were found.

The authors concluded that increased BMI is associated with an increase in upper GI symptoms, bloating, and diarrhea. They noted, however, that causeand- effect relationships and the mechanisms of these associations require further investigation.

Latest Articles
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Latest Issues